This thesis delves into the complex neurological condition of migraines, providing an overview of its mechanisms and impacts. It then outlines classical treatments for migraines, including prescription medications, while noting their effectiveness and limitations. A significant portion is dedicated to exploring innovative therapies, specifically the advent of CGRP-targeted treatments and Lasmiditan, which offer better efficacy and reduced side effects compared to traditional methods. The discussion emphasizes the transformative potential of these new approaches in the treatment landscape. Finally, it hints at future advancements in migraine therapy, suggesting ongoing progress in the field.